Abstract: Disclosed includes an ophthalmic composition for treating an eye condition and a method for treating an eye condition. The composition comprising a DNA repair enzyme, which can be administered to an eye of the patient in need. Some of the eye conditions that can be treated include glaucoma, optic neuritis, retinopathy, cataracts, macular degeneration, corneal abrasions or ulcers, melanomas, basal cell carcinomas, and other malignant or benign tumors.

Abstract: A method of nonsurgical orbital fat reduction includes providing an electromagnetic energy system that includes an electromagnetic energy source and a patient interface coupled to the electromagnetic energy source. The patient interface includes an elongate member configured to deliver electromagnetic energy generated by the electromagnetic energy source to tissue of a medical patient. The method also includes inserting at least a distal portion of the elongate member into an orbital fat pad of the medical patient and delivering a sufficient amount of electromagnetic energy from the electromagnetic energy source to the orbital fat pad to cause the orbital fat pad to shrink in volume.

Abstract: Systems and methods for quantifying skin damage, such as oxidative skin damage from sun exposure, are disclosed herein. The skin damage can be quantified using by using a proximity-based assay that measures a skin marker, such as peptide 3R. The quantitative data can be advantageously used to serve, for example, as markers of overall dermatologic health, risk stratification factors, markers for the presence of dermatologic conditions, including clinical disease, predictors of subclinical and/or minimal residual disease presence, determinants of treatment response and disease progression, and prognosticators of patient outcome.

Abstract: Disclosed is a method of preventing or treating a condition of the gastrointestinal tract. The method includes the steps of providing a DNA repair composition, the DNA repair composition comprising at least one DNA repair enzyme, the DNA repair composition configured for administration within the gastrointestinal tract of a patient; and administering the DNA repair composition to the patient, such that the DNA repair composition is absorbed within the gastrointestinal tract of the patient to treat the condition of the gastrointestinal tract.

Abstract: Disclosed is a method of preventing or treating a condition of the gastrointestinal tract. The method includes the steps of providing a DNA repair composition, the DNA repair composition comprising at least one DNA repair enzyme, the DNA repair composition configured for administration within the gastrointestinal tract of a patient; and administering the DNA repair composition to the patient, such that the DNA repair composition is absorbed within the gastrointestinal tract of the patient to treat the condition of the gastrointestinal tract.

Abstract: A method of nonsurgical orbital fat reduction includes providing an electromagnetic energy system that includes an electromagnetic energy source and a patient interface coupled to the electromagnetic energy source. The patient interface includes an elongate member configured to deliver electromagnetic energy generated by the electromagnetic energy source to tissue of a medical patient. The method also includes inserting at least a distal portion of the elongate member into an orbital fat pad of the medical patient and delivering a sufficient amount of electromagnetic energy from the electromagnetic energy source to the orbital fat pad to cause the orbital fat pad to shrink in volume.

Abstract: Disclosed is a method of preventing or treating a condition of the gastrointestinal tract. The method includes the steps of providing a DNA repair composition, the DNA repair composition comprising at least one DNA repair enzyme, the DNA repair composition configured for administration within the gastrointestinal tract of a patient; and administering the DNA repair composition to the patient, such that the DNA repair composition is absorbed within the gastrointestinal tract of the patient to treat the condition of the gastrointestinal tract.

Abstract: An electromagnetic energy system adapted to reduce scar formation associated with a skin wound includes a memory, an electromagnetic energy source, an optical energy conduit, a handpiece, and a controller. The memory includes predetermined beam parameter information. The electromagnetic energy source is adapted to generate an electromagnetic energy beam having at least one beam parameter corresponding to the predetermined beam parameter information. The electromagnetic energy beam having the at least one beam parameter is adapted to reduce scar formation associated with a skin wound. The optical energy conduit has a proximal and a distal end, and is coupled to the electromagnetic energy source at the proximal end. The handpiece is coupled to the distal end of the optical energy conduit. The controller is adapted to activate the electromagnetic energy source to deliver to a treatment area near the skin wound.

Abstract: A method of reducing scar formation associated with a skin wound includes providing an electromagnetic energy source, delivering energy from the electromagnetic energy source to opposing edges of a skin wound, and sealing the wound after delivering the energy. The electromagnetic energy source can include a laser, such as a fractional laser, including a fractional CO2 laser. Handpieces configured to reduce scar formation include one or more of a tissue eversion system, a medication delivery system, and a wound sealing system.

Abstract: A method of nonsurgical orbital fat reduction includes providing an electromagnetic energy system that includes an electromagnetic energy source and a patient interface coupled to the electromagnetic energy source. The patient interface includes an elongate member configured to deliver electromagnetic energy generated by the electromagnetic energy source to tissue of a medical patient. The method also includes inserting at least a distal portion of the elongate member into an orbital fat pad of the medical patient and delivering a sufficient amount of electromagnetic energy from the electromagnetic energy source to the orbital fat pad to cause the orbital fat pad to shrink in volume.

Abstract: A skin care composition can include a growth factor, such as an epidermal and/or keratinocyte growth factor (EGF, KGF), a DNA repair enzyme encapsulated by a liposome, and a carrier suitable for topical administration of the EGF and/or KGF and DNA repair enzyme to a subject's skin. One, two, or more modalities, such as sonophoresis, can be used to synergistically increase transdermal penetration of compositions. Also disclosed herein is a therapeutic agent for preventing or treating a condition of the gastrointestinal tract.

Abstract: An electromagnetic energy system configured to reduce scar formation associated with a skin wound includes: an electromagnetic energy source configured to generate an electromagnetic energy beam having a plurality of beam parameters; an optical energy conduit having a proximal and a distal end, said optical energy conduit coupled to said electromagnetic energy source at said proximal end; a handpiece coupled to the distal end of said optical energy conduit; and a memory, comprising predetermined, stored values of said plurality of beam parameters, said predetermined values of said beam parameters configured to reduce scar formation associated with a skin wound.

Abstract: A method of reducing scar formation associated with a skin wound includes providing an electromagnetic energy source, delivering energy from the electromagnetic energy source to opposing edges of a skin wound, and sealing the wound after delivering the energy. The electromagnetic energy source can include a laser, such as a fractional laser, including a fractional CO2 laser. Handpieces configured to reduce scar formation include one or more of a tissue eversion system, a medication delivery system, and a wound sealing system.